The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Monoclonal antibody to murine gamma interferon inhibits lymphokine-induced antiviral and macrophage tumoricidal activities.
Open accessAbstract
Fusion of rat immune spleen cells with mouse myeloma cells resulted in the formation of a stable hybridoma that secretes monoclonal antibody (MAb) directed against murine gamma interferon ( MuIFN -gamma). This MAb specifically neutralized the antiviral activity of a variety of MuIFN -gamma preparations, including a sample produced by recombinant DNA technologies. In contrast, the antiviral activities of a mixture of MuIFN -alpha plus MuIFN -beta, as well as those of rat or human IFN-gamma, were not neutralized by this antibody. The ability of the MAb to inhibit lymphokine-induced macrophage activation was also tested. It was found that in relation to the quantity of antibody needed to completely neutralize antiviral activity, much higher concentrations of MAb were required to abolish the capacity of lymphokine preparations to induce macrophage tumoricidal activity in vitro. The MAb was also coupled to cyanogen bromide-activated Sepharose beads and used as an immunoadsorbent. By reacting lymphokines with MAb coupled to an insoluble matrix, it was possible to show that this immobilized antibody completely and specifically removed from the lymphokine preparations the ability both to invoke macrophage tumoricidal activity and to mediate antiviral activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Continuous cultures of fused cells secreting antibody of predefined specificity
KÖHLER, G., & MILSTEIN, C. (1975) · Nature · doi:10.1038/256495a0 · Cited by 17,229
Nathan, C. F., Murray, H. W., Wiebe, M. E., & Rubin, B. Y. (1983) · The Journal of experimental medicine · doi:10.1084/jem.158.3.670 · Cited by 1,962
Production of High-Titered Interferon in Cultures of Human Diploid Cells
Havell, E. A., & Vilček, J. (1972) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.2.6.476 · Cited by 470
Self-citationPace, J. L., Russell, S. W., Torres, B. A., Johnson, H. M., & Gray, P. W. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.5.2011 · Cited by 442
Mediators of Immunity: Lymphokines and Monokines
Rocklin, R. E., Bendtzen, K., & Greineder, D. (1980) · Advances in Immunology · doi:10.1016/s0065-2776(08)60043-7 · Cited by 173
Pace, J. L., & Russell, S. W. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.126.5.1863 · Cited by 170
Havell, E. A., Spitalny, G. L., & Patel, P. J. (1982) · The Journal of Experimental Medicine · doi:10.1084/jem.156.1.112 · Cited by 93
Self-citationRubin, B. Y., Bartal, A. H., Anderson, S. L., Millet, S. K., Hirshaut, Y., & Feit, C. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.3.1019 · Cited by 47
Cited by
Heinzel, F. P., Sadick, M. D., Holaday, B. J., Coffman, R. L., & Locksley, R. M. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.1.59 · Cited by 1,454
Endotoxin signal transduction in macrophages
Sweet, M. J., & Hume, D. A. (1996) · Journal of Leukocyte Biology · doi:10.1002/jlb.60.1.8 · Cited by 793
Sadick, M. D., Heinzel, F. P., Holaday, B. J., Pu, R. T., Dawkins, R. S., & Locksley, R. M. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.1.115 · Cited by 620
Greenberg, P. D. (1991) · Advances in Immunology · doi:10.1016/s0065-2776(08)60778-6 · Cited by 603
Buchmeier, N. A., & Schreiber, R. D. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.21.7404 · Cited by 542
Xu-Amano, J., Kiyono, H., Jackson, R. J., Staats, H. F., Fujihashi, K., Burrows, P. D., Elson, C. O., Pillai, S., & McGhee, J. R. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.4.1309 · Cited by 450
Yoshimoto, T., Okamura, H., Tagawa, Y.-I., Iwakura, Y., & Nakanishi, K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3948 · Cited by 381
A Macrophage-Derived Factor Required by Plasmacytomas for Survival and Proliferation in Vitro
Nordan, R. P., & Potter, M. (1986) · Science · doi:10.1126/science.3726549 · Cited by 375
Polić, B., Hengel, H., Krmpotić, A., Trgovcich, J., Pavić, I., Lučin, P., Jonjić, S., & Koszinowski, U. H. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.6.1047 · Cited by 361
Piguet, P. F., Grau, G. E., Hauser, C., & Vassalli, P. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.3.673 · Cited by 340
Germann, T., Bongartz, M., Dlugonska, H., Hess, H., Schmitt, E., Kolbe, L., Kölsch, E., Podlaski, F. J., Gately, M. K., & Rüde, E. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250329 · Cited by 324
Grau, G. E., Heremans, H., Piguet, P. F., Pointaire, P., Lambert, P. H., Billiau, A., & Vassalli, P. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.14.5572 · Cited by 318
Qin, L., Ding, Y., Pahud, D. R., Chang, E., Imperiale, M. J., & Bromberg, J. S. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.17-2019 · Cited by 315
Treatment of Visceral Leishmaniasis with Pentavalent Antimony and Interferon Gamma
Badaro, R., Falcoff, E., Badaro, F. S., Carvalho, E. M., Pedral-Sampaio, D., Barral, A., Carvalho, J. S., Barral-Netto, M., Brandely, M., Silva, L., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001043220104 · Cited by 310
Manz, R., Assenmacher, M., Pflüger, E., Miltenyi, S., & Radbruch, A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.6.1921 · Cited by 303
Iwamoto, I., Nakajima, H., Endo, H., & Yoshida, S. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.2.573 · Cited by 302
Assenmacher, M., Schmitz, J., & Radbruch, A. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240513 · Cited by 296
Schmitt, E., Hoehn, P., Huels, C., Goedert, S., Palm, N., Rüde, E., & Germann, T. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240403 · Cited by 287
Nauciel, C., & Espinasse-Maes, F. (1992) · Infection and Immunity · doi:10.1128/iai.60.2.450-454.1992 · Cited by 283
Watanabe, Y., Kuribayashi, K., Miyatake, S., Nishihara, K., Nakayama, E., Taniyama, T., & Sakata, T. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.23.9456 · Cited by 282
Regulation of T‐Cell Activation; Differences among T‐Cell Subsets
Gajewskj, T. F., Schell, S. R., Nau, G., & Fitch, F. W. (1989) · Immunological Reviews · doi:10.1111/j.1600-065x.1989.tb00543.x · Cited by 268
Prevention of diabetes in NOD mice treated with antibody to murine IFNγ
Debray-Sachs, M., Carnaud, C., Boitard, C., Cohen, H., Gresser, I., Bedossa, P., & Bach, J.-F. (1991) · Journal of Autoimmunity · doi:10.1016/0896-8411(91)90021-4 · Cited by 258
Enhancement of experimental metastasis by tumor necrosis factor.
Orosz, P., Echtenacher, B., Falk, W., Rüschoff, J., Weber, D., & Männel, D. N. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.5.1391 · Cited by 198
“9 [5-56]) had no influence on the number of lung metastases on day 11, 0.”
BackgroundThe Mechanism of Superantigen-Mediated Toxic Shock: Not a Simple Th1 Cytokine Storm
Faulkner, L., Cooper, A., Fantino, C., Altmann, D. M., & Sriskandan, S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.6870 · Cited by 122
“12 (35) or the isotype-matched control, L2-3D9 (CellTech) 1 h before or 4 h after challenge and 400 g/mouse of purified rat anti-IFNAb R4-6A2 (36) (provided by Dr.”
MethodInfluential
Metadata
- Authors
- Spitalny, G. L., & Havell, E. A.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1984-05-01
- Volume
- 159
- Issue
- 5
- Pages
- 1560-1565
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2017596457
- Cited by
- 367
- References
- 8
- FWCI
- 5.36
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.